The Communication Between Us And The Health Care Professionals Commence
ClevelandClinic November 03, 2010
Two advanced drugs called hepatitis C protease inhibitors now awaiting approval from the Food and Drug Administration (FDA) have the ability to fundamentally change the treatment for hepatitis C for patients who have not responded to previous therapies. Both new drugs have been very successful in curing test subjects in clinical trials, which represents a big step forward in successfully battling this debilitating disease
.
.
No comments:
Post a Comment